1
|
Galante D, Leone AM, Migliaro S, DI Giusto F, Anastasia G, Petrolati E, Viceré A, Zimbardo G, Cialdella P, Basile E, D'Amario D, Vergallo R, Montone RA, Buffon A, Romagnoli E, Aurigemma C, Burzotta F, Trani C, Crea F. Prognostic value of combined fractional flow reserve and pressure-bounded coronary flow reserve: outcomes in FFR and Pb-CFR assessment. Minerva Cardiol Angiol 2024; 72:152-162. [PMID: 37930018 DOI: 10.23736/s2724-5683.23.06399-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2023]
Abstract
BACKGROUND Coronary flow reserve (CFR) has an emerging role to predict outcome in patients with and without flow-limiting stenoses. However, the role of its surrogate pressure bounded-CFR (Pb-CFR) is controversial. We investigated the usefulness of combined use of fractional flow reserve (FFR) and Pb-CFR to predict outcomes. METHODS This is a sub-study of the PROPHET-FFR Trial, including patients with chronic coronary syndrome and functionally tested coronary lesions. Patients were divided into four groups based on positive or negative FFR (cut-off 0.80) and preserved (lower boundary ≥2) or reduced (upper boundary <2) Pb-CFR: Group1 FFR≤0.80/ Pb-CFR <2; Group 2 FFR≤0.80/Pb-CFR≥2; Group 3 FFR >0.80/Pb-CFR<2; Group 4 FFR>0.80/Pb-CFR≥2. Lesions with positive FFR were treated with PCI. Primary endpoint was the rate of major adverse cardiac events (MACEs), defined as a composite of death from any cause, myocardial infarction, target vessel revascularization, unplanned cardiac hospitalization at 36-months. RESULTS A total of 609 patients and 816 lesions were available for the analysis. At Kaplan-Meier analysis MACEs rate was significantly different between groups (36.7% Group 1, 27.4% Group 2, 19.2% Group 3, 22.6% Group 4, P=0.019) and more prevalent in groups with FFR≤0.80 irrespective of Pb-CFR. In case of discrepancy, no difference in MACEs were observed between groups stratified by Pb-CFR. FFR≤0.80 was associated with an increased MACEs rate (30.2% vs. 21.5%, P<0.01) while Pb-CFR<2 was not (24.5% vs. 24.2% Pb-CFR≥2 P=0.67). CONCLUSIONS FFR confirms its ability to predict outcomes in patients with intermediate coronary stenoses. Pb-CFR does not add any relevant prognostic information.
Collapse
Affiliation(s)
- Domenico Galante
- Sacred Heart Catholic University, Rome, Italy
- Operative Unit of Diagnostic and Interventional Cardiology, Fatebenefratelli Gemelli Isola Tiberina Hospital, Rome, Italy
| | - Antonio M Leone
- Sacred Heart Catholic University, Rome, Italy -
- Operative Unit of Diagnostic and Interventional Cardiology, Fatebenefratelli Gemelli Isola Tiberina Hospital, Rome, Italy
- Department of Cardiovascular Sciences, IRCCS A. Gemelli University Polyclinic Foundation, Rome, Italy
| | | | | | | | | | | | | | | | | | - Domenico D'Amario
- Sacred Heart Catholic University, Rome, Italy
- Department of Cardiovascular Sciences, IRCCS A. Gemelli University Polyclinic Foundation, Rome, Italy
| | - Rocco Vergallo
- Department of Cardiovascular Sciences, IRCCS A. Gemelli University Polyclinic Foundation, Rome, Italy
| | - Rocco A Montone
- Department of Cardiovascular Sciences, IRCCS A. Gemelli University Polyclinic Foundation, Rome, Italy
| | - Antonino Buffon
- Sacred Heart Catholic University, Rome, Italy
- Department of Cardiovascular Sciences, IRCCS A. Gemelli University Polyclinic Foundation, Rome, Italy
| | - Enrico Romagnoli
- Department of Cardiovascular Sciences, IRCCS A. Gemelli University Polyclinic Foundation, Rome, Italy
| | - Cristina Aurigemma
- Department of Cardiovascular Sciences, IRCCS A. Gemelli University Polyclinic Foundation, Rome, Italy
| | - Francesco Burzotta
- Sacred Heart Catholic University, Rome, Italy
- Department of Cardiovascular Sciences, IRCCS A. Gemelli University Polyclinic Foundation, Rome, Italy
| | - Carlo Trani
- Sacred Heart Catholic University, Rome, Italy
- Department of Cardiovascular Sciences, IRCCS A. Gemelli University Polyclinic Foundation, Rome, Italy
| | - Filippo Crea
- Sacred Heart Catholic University, Rome, Italy
- Department of Cardiovascular Sciences, IRCCS A. Gemelli University Polyclinic Foundation, Rome, Italy
| |
Collapse
|
2
|
Ikeda K, Kubo T, Murasawa T, Deguchi H, Takihara K, Nukariya M, Kuwahara A, Nakayama T, Kitamura M, Tezuka T, Takagi R, Ito R, Kazawa S, Iwasaki Y, Yamada S, Satomi K, Tanaka N. Diagnostic performance of pressure-bounded coronary flow reserve. Cardiovasc Interv Ther 2024; 39:164-172. [PMID: 38329574 DOI: 10.1007/s12928-024-00983-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2023] [Accepted: 12/26/2023] [Indexed: 02/09/2024]
Abstract
Fluid dynamics studies have proposed that coronary flow reserve can be calculated from coronary artery pressure instead of coronary blood flow. We sought to investigate the diagnostic performance of pressure-bounded coronary flow reserve (pb-CFR) compared with CFR measured by conventional thermodilution method (CFRthermo) in the clinical setting. Pressure guidewire was used to measure CFRthermo and fractional flow reserve (FFR) in left anterior descending coronary artery in 62 patients with stable coronary artery disease. Pb-CFR was calculated only with resting distal coronary artery pressure (Pd), resting aortic pressure (Pa) and FFR. Pb-CFR was moderately correlated with CFRthermo (r = 0.54, P < 0.001). Pb-CFR showed a poor agreement with CFRthermo, presenting large values of mean difference and root mean square deviation (1.5 ± 1.4). Pb-CFR < 2.0 predicted CFRthermo < 2.0 with an accuracy of 79%, sensitivity of 83%, specificity of 78%, positive predictive value of 48%, negative predictive value of 95%. The discordance presenting CFRthermo < 2.0 and pb-CFR ≥ 2.0 was associated with diffuse disease (P < 0.001). The discordance presenting CFRthermo ≥ 2 and pb-CFR < 2 was associated with a high FFR (P = 0.002). Pb-CFR showed moderate correlation and poor agreement with CFRthermo. Pb-CFR might be reliable in excluding epicardial coronary artery disease and microcirculatory disorders.
Collapse
Affiliation(s)
- Kazumasa Ikeda
- Department of Cardiology, Tokyo Medical University Hachioji Medical Center, 1163 Tate-machi, Hachioji, Tokyo, 193-0998, Japan
| | - Takashi Kubo
- Department of Cardiology, Tokyo Medical University Hachioji Medical Center, 1163 Tate-machi, Hachioji, Tokyo, 193-0998, Japan.
| | - Takahide Murasawa
- Department of Clinical Engineering, Tokyo Medical University Hachioji Medical Center, Hachioji, Tokyo, Japan
| | - Haruyuki Deguchi
- Department of Cardiology, Tokyo Medical University Hachioji Medical Center, 1163 Tate-machi, Hachioji, Tokyo, 193-0998, Japan
| | - Kazuya Takihara
- Department of Cardiology, Tokyo Medical University Hachioji Medical Center, 1163 Tate-machi, Hachioji, Tokyo, 193-0998, Japan
| | - Masato Nukariya
- Department of Cardiology, Tokyo Medical University Hachioji Medical Center, 1163 Tate-machi, Hachioji, Tokyo, 193-0998, Japan
| | - Asuka Kuwahara
- Department of Cardiology, Tokyo Medical University Hachioji Medical Center, 1163 Tate-machi, Hachioji, Tokyo, 193-0998, Japan
| | - Tomoaki Nakayama
- Department of Cardiology, Tokyo Medical University Hachioji Medical Center, 1163 Tate-machi, Hachioji, Tokyo, 193-0998, Japan
| | - Miki Kitamura
- Department of Cardiology, Tokyo Medical University Hachioji Medical Center, 1163 Tate-machi, Hachioji, Tokyo, 193-0998, Japan
| | - Taiyo Tezuka
- Department of Cardiology, Tokyo Medical University Hachioji Medical Center, 1163 Tate-machi, Hachioji, Tokyo, 193-0998, Japan
| | - Ryu Takagi
- Department of Cardiology, Tokyo Medical University Hachioji Medical Center, 1163 Tate-machi, Hachioji, Tokyo, 193-0998, Japan
| | - Ryosuke Ito
- Department of Cardiology, Tokyo Medical University Hachioji Medical Center, 1163 Tate-machi, Hachioji, Tokyo, 193-0998, Japan
| | - Shuichiro Kazawa
- Department of Cardiology, Tokyo Medical University Hachioji Medical Center, 1163 Tate-machi, Hachioji, Tokyo, 193-0998, Japan
| | - Yoichi Iwasaki
- Department of Cardiology, Tokyo Medical University Hachioji Medical Center, 1163 Tate-machi, Hachioji, Tokyo, 193-0998, Japan
| | - Satoshi Yamada
- Department of Cardiology, Tokyo Medical University Hachioji Medical Center, 1163 Tate-machi, Hachioji, Tokyo, 193-0998, Japan
| | - Kazuhiro Satomi
- Department of Cardiology, Tokyo Medical University, Tokyo, Japan
| | - Nobuhiro Tanaka
- Department of Cardiology, Tokyo Medical University Hachioji Medical Center, 1163 Tate-machi, Hachioji, Tokyo, 193-0998, Japan
| |
Collapse
|
3
|
Ciaramella L, Di Serafino L, Mitrano L, De Rosa ML, Carbone C, Rea FS, Monaco S, Scalamogna M, Cirillo P, Esposito G. Invasive Assessment of Coronary Microcirculation: A State-of-the-Art Review. Diagnostics (Basel) 2023; 14:86. [PMID: 38201395 PMCID: PMC10795746 DOI: 10.3390/diagnostics14010086] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2023] [Revised: 12/28/2023] [Accepted: 12/28/2023] [Indexed: 01/12/2024] Open
Abstract
A significant proportion of patients presenting with signs and symptoms of myocardial ischemia have no "significant" epicardial disease; thereby, the assessment of coronary microcirculation gained an important role in improving diagnosis and guiding therapy. In fact, coronary microvascular dysfunction (CMD) could be found in a large proportion of these patients, supporting both symptoms and signs of myocardial ischemia. However, CMD represents a diagnostic challenge for two main reasons: (1) the small dimension of the coronary microvasculature prevents direct angiographic visualization, and (2) despite the availability of specific diagnostic tools, they remain invasive and underused in the current clinical practice. For these reasons, CMD remains underdiagnosed, and most of the patients remain with no specific treatment and quality-of-life-limiting symptoms. Of note, recent evidence suggests that a "full physiology" approach for the assessment of the whole coronary vasculature may offer a significant benefit in terms of symptom improvement among patients presenting with ischemia and non-obstructive coronary artery disease. We analyze the pathophysiology of coronary microvascular dysfunction, providing the readers with a guide for the invasive assessment of coronary microcirculation, together with the available evidence supporting its use in clinical practice.
Collapse
Affiliation(s)
| | - Luigi Di Serafino
- Department of Advanced Biomedical Sciences, University of Naples Federico II, Via Pansini 5, 80131 Naples, Italy; (L.C.); (L.M.); (M.L.D.R.); (C.C.); (F.S.R.); (S.M.); (M.S.); (P.C.); (G.E.)
| | | | | | | | | | | | | | | | | |
Collapse
|
4
|
Clinical use of physiological lesion assessment using pressure guidewires: an expert consensus document of the Japanese association of cardiovascular intervention and therapeutics-update 2022. Cardiovasc Interv Ther 2022; 37:425-439. [PMID: 35543896 DOI: 10.1007/s12928-022-00863-1] [Citation(s) in RCA: 24] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2022] [Accepted: 04/16/2022] [Indexed: 01/10/2023]
Abstract
Fractional flow reserve and instantaneous wave-free ratio are widely accepted and recommended in Western and Japanese guidelines for appropriate percutaneous coronary intervention. There are, however, many differences in clinical situations between Japan and Western countries. Therefore, the Task Force on coronary physiology of the Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT) has proposed an expert consensus document to summarize current evidence and suggest the practical use of physiological lesion assessment in Japan.
Collapse
|
5
|
Morris PD, Gosling R, Zwierzak I, Evans H, Aubiniere-Robb L, Czechowicz K, Evans PC, Hose DR, Lawford PV, Narracott AJ, Gunn JP. A novel method for measuring absolute coronary blood flow and microvascular resistance in patients with ischaemic heart disease. Cardiovasc Res 2021; 117:1567-1577. [PMID: 32666101 PMCID: PMC8152717 DOI: 10.1093/cvr/cvaa220] [Citation(s) in RCA: 31] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/13/2020] [Revised: 05/27/2020] [Accepted: 07/07/2020] [Indexed: 01/28/2023] Open
Abstract
AIMS Ischaemic heart disease is the reduction of myocardial blood flow, caused by epicardial and/or microvascular disease. Both are common and prognostically important conditions, with distinct guideline-indicated management. Fractional flow reserve (FFR) is the current gold-standard assessment of epicardial coronary disease but is only a surrogate of flow and only predicts percentage flow changes. It cannot assess absolute (volumetric) flow or microvascular disease. The aim of this study was to develop and validate a novel method that predicts absolute coronary blood flow and microvascular resistance (MVR) in the catheter laboratory. METHODS AND RESULTS A computational fluid dynamics (CFD) model was used to predict absolute coronary flow (QCFD) and coronary MVR using data from routine invasive angiography and pressure-wire assessment. QCFD was validated in an in vitro flow circuit which incorporated patient-specific, three-dimensional printed coronary arteries; and then in vivo, in patients with coronary disease. In vitro, QCFD agreed closely with the experimental flow over all flow rates [bias +2.08 mL/min; 95% confidence interval (error range) -4.7 to +8.8 mL/min; R2 = 0.999, P < 0.001; variability coefficient <1%]. In vivo, QCFD and MVR were successfully computed in all 40 patients under baseline and hyperaemic conditions, from which coronary flow reserve (CFR) was also calculated. QCFD-derived CFR correlated closely with pressure-derived CFR (R2 = 0.92, P < 0.001). This novel method was significantly more accurate than Doppler-wire-derived flow both in vitro (±6.7 vs. ±34 mL/min) and in vivo (±0.9 vs. ±24.4 mmHg). CONCLUSIONS Absolute coronary flow and MVR can be determined alongside FFR, in absolute units, during routine catheter laboratory assessment, without the need for additional catheters, wires or drug infusions. Using this novel method, epicardial and microvascular disease can be discriminated and quantified. This comprehensive coronary physiological assessment may enable a new level of patient stratification and management.
Collapse
Affiliation(s)
- Paul D Morris
- Mathematical Modelling in Medicine Group, Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield , UK
- Department of Cardiology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
- Insigneo Institute for In Silico Medicine, University of Sheffield, Sheffield, UK
| | - Rebecca Gosling
- Mathematical Modelling in Medicine Group, Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield , UK
- Department of Cardiology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
- Insigneo Institute for In Silico Medicine, University of Sheffield, Sheffield, UK
| | - Iwona Zwierzak
- Mathematical Modelling in Medicine Group, Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield , UK
- Insigneo Institute for In Silico Medicine, University of Sheffield, Sheffield, UK
| | - Holli Evans
- Mathematical Modelling in Medicine Group, Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield , UK
| | - Louise Aubiniere-Robb
- Mathematical Modelling in Medicine Group, Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield , UK
| | - Krzysztof Czechowicz
- Mathematical Modelling in Medicine Group, Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield , UK
| | - Paul C Evans
- Mathematical Modelling in Medicine Group, Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield , UK
- Insigneo Institute for In Silico Medicine, University of Sheffield, Sheffield, UK
- The Bateson Centre, University of Sheffield, Sheffield, UK
| | - D Rodney Hose
- Mathematical Modelling in Medicine Group, Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield , UK
- Insigneo Institute for In Silico Medicine, University of Sheffield, Sheffield, UK
- Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
| | - Patricia V Lawford
- Mathematical Modelling in Medicine Group, Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield , UK
- Insigneo Institute for In Silico Medicine, University of Sheffield, Sheffield, UK
| | - Andrew J Narracott
- Mathematical Modelling in Medicine Group, Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield , UK
- Insigneo Institute for In Silico Medicine, University of Sheffield, Sheffield, UK
| | - Julian P Gunn
- Mathematical Modelling in Medicine Group, Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield , UK
- Department of Cardiology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
- Insigneo Institute for In Silico Medicine, University of Sheffield, Sheffield, UK
| |
Collapse
|
6
|
Szabó GT, Üveges Á, Tar B, Ágoston A, Dorj A, Jenei C, Kolozsvári R, Csippa B, Czuriga D, Kőszegi Z. The Holistic Coronary Physiology Display: Calculation of the Flow Separation Index in Vessel-Specific Individual Flow Range during Fractional Flow Reserve Measurement Using 3D Coronary Reconstruction. J Clin Med 2021; 10:jcm10091910. [PMID: 33924961 PMCID: PMC8124623 DOI: 10.3390/jcm10091910] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2021] [Revised: 04/19/2021] [Accepted: 04/25/2021] [Indexed: 12/25/2022] Open
Abstract
In order to make optimal decisions on the treatment of atherosclerotic coronary heart disease (CHD), appropriate evaluation is necessary, including both the anatomical and physiological assessment of the coronary arteries. According to current guidelines, a fractional flow reserve (FFR)-based clinical decision is recommended, but coronary flow reserve (CFR) measurements and microvascular evaluation should also be considered in special cases for a detailed exploration of the coronary disease state. We aimed to generate an extended physiological evaluation during routine FFR measurement and define a new pathological flow-related prognostic factor. Fluid dynamic equations were applied to calculate CFR on the basis of the three-dimensional (3D) reconstruction of the invasively acquired coronary angiogram and the measured intracoronary pressure data. A new, potentially robust prognostic parameter of a coronary lesion called the "flow separation index" (FSi), which is thought to detect the pathological flow amount through a stenosis was introduced in a vessel-specific flow range. Correlations between FSi and the clinically established physiological indices (CFR and FFR) were determined. The FSi was calculated in 19 vessels of 16 patients, including data from the pre- and post-stent revascularization treatment of 3 patients. There was no significant correlation between the FSi and the CFR (r = -0.23, p = 0.34); however, there was significant negative correlation between the FSi and the FFR (r = -0.66, p = 0.002). An even stronger correlation was found between the FSi and the ratio of the resting pressure ratio and the FFR (r = 0.92, p < 0.0001). The diagnostic power of the FSi for predicting the FFR value of <0.80, as a gold standard prognostic factor, was tested by receiver operating characteristic analysis. FSi > 0.022 proved to be the cutoff value of the prediction of a pathologically low FFR with a 0.856 area under the curve (95% confidence interval: 0.620 to 0.972). The present flow-pressure-velocity display provides a comprehensive summary of patient-specific pathophysiology in CHD. The consequences of epicardial stenoses can be evaluated together with their complex relations to microvascular conditions. Based on these values, clinical decision-making concerning both pharmacological therapy and percutaneous or surgical revascularization may be more precisely guided.
Collapse
Affiliation(s)
- Gábor Tamás Szabó
- Division of Cardiology, Department of Cardiology, Faculty of Medicine, University of Debrecen, Móricz Zs. krt. 22, 4032 Debrecen, Hungary; (G.T.S.); (A.D.); (C.J.); (R.K.); (D.C.)
- Kálmán Laki Doctoral School of Biomedical and Clinical Sciences, University of Debrecen, 4032 Debrecen, Hungary; (Á.Ü.); (B.T.); (A.Á.)
| | - Áron Üveges
- Kálmán Laki Doctoral School of Biomedical and Clinical Sciences, University of Debrecen, 4032 Debrecen, Hungary; (Á.Ü.); (B.T.); (A.Á.)
- Szabolcs–Szatmár–Bereg County Hospitals and University Teaching Hospital, 4400 Nyíregyháza, Hungary
| | - Balázs Tar
- Kálmán Laki Doctoral School of Biomedical and Clinical Sciences, University of Debrecen, 4032 Debrecen, Hungary; (Á.Ü.); (B.T.); (A.Á.)
- Szabolcs–Szatmár–Bereg County Hospitals and University Teaching Hospital, 4400 Nyíregyháza, Hungary
| | - András Ágoston
- Kálmán Laki Doctoral School of Biomedical and Clinical Sciences, University of Debrecen, 4032 Debrecen, Hungary; (Á.Ü.); (B.T.); (A.Á.)
- Szabolcs–Szatmár–Bereg County Hospitals and University Teaching Hospital, 4400 Nyíregyháza, Hungary
| | - Azzaya Dorj
- Division of Cardiology, Department of Cardiology, Faculty of Medicine, University of Debrecen, Móricz Zs. krt. 22, 4032 Debrecen, Hungary; (G.T.S.); (A.D.); (C.J.); (R.K.); (D.C.)
| | - Csaba Jenei
- Division of Cardiology, Department of Cardiology, Faculty of Medicine, University of Debrecen, Móricz Zs. krt. 22, 4032 Debrecen, Hungary; (G.T.S.); (A.D.); (C.J.); (R.K.); (D.C.)
- Kálmán Laki Doctoral School of Biomedical and Clinical Sciences, University of Debrecen, 4032 Debrecen, Hungary; (Á.Ü.); (B.T.); (A.Á.)
| | - Rudolf Kolozsvári
- Division of Cardiology, Department of Cardiology, Faculty of Medicine, University of Debrecen, Móricz Zs. krt. 22, 4032 Debrecen, Hungary; (G.T.S.); (A.D.); (C.J.); (R.K.); (D.C.)
- Kálmán Laki Doctoral School of Biomedical and Clinical Sciences, University of Debrecen, 4032 Debrecen, Hungary; (Á.Ü.); (B.T.); (A.Á.)
| | - Benjamin Csippa
- Department of Hydrodynamic Systems, Budapest University of Technology and Economics, 1111 Budapest, Hungary;
| | - Dániel Czuriga
- Division of Cardiology, Department of Cardiology, Faculty of Medicine, University of Debrecen, Móricz Zs. krt. 22, 4032 Debrecen, Hungary; (G.T.S.); (A.D.); (C.J.); (R.K.); (D.C.)
- Kálmán Laki Doctoral School of Biomedical and Clinical Sciences, University of Debrecen, 4032 Debrecen, Hungary; (Á.Ü.); (B.T.); (A.Á.)
| | - Zsolt Kőszegi
- Division of Cardiology, Department of Cardiology, Faculty of Medicine, University of Debrecen, Móricz Zs. krt. 22, 4032 Debrecen, Hungary; (G.T.S.); (A.D.); (C.J.); (R.K.); (D.C.)
- Kálmán Laki Doctoral School of Biomedical and Clinical Sciences, University of Debrecen, 4032 Debrecen, Hungary; (Á.Ü.); (B.T.); (A.Á.)
- Szabolcs–Szatmár–Bereg County Hospitals and University Teaching Hospital, 4400 Nyíregyháza, Hungary
- Correspondence: ; Tel./Fax: +36-52-255928
| |
Collapse
|
7
|
Scarsini R, De Maria GL, Shanmuganathan M, Kotronias R, Terentes-Printzios D, Langrish J, Lucking A, Ribichini FL, Choudhury R, Kharbanda RKK, Ferreira V, Channon K, Banning AP. Pressure-bounded coronary flow reserve to assess the extent of microvascular dysfunction in patients with ST-elevation acute myocardial infarction. EUROINTERVENTION 2021; 16:1434-1443. [PMID: 31854300 PMCID: PMC9754025 DOI: 10.4244/eij-d-19-00674] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
AIMS Assessment of microvascular function in patients with ST-elevation acute myocardial infarction (STEMI) may be useful to determine treatment strategy. The possible role of pressure-bounded coronary flow reserve (pb-CFR) in this setting has not been determined. In this study we aimed to compare pb-CFR with thermodilution-derived physiology including the index of microcirculatory resistance (IMR) and CFRthermo in a consecutive series of patients enrolled in the OxAMI study. Moreover, we aimed to assess the presence of microvascular obstruction (MVO) and myocardial injury on cardiovascular magnetic resonance (CMR) imaging performed at 48 hours and six months in STEMI patients stratified according to pb-CFR. METHODS AND RESULTS Thermodilution-pressure-wire assessment of the infarct-related artery was performed in 148 STEMI patients before stenting and/or at completion of primary percutaneous coronary intervention (PPCI). The extent of the myocardial injury was assessed with CMR imaging at 48 hours and six months after STEMI. Post-PPCI pb-CFR was impaired (<2) and normal (>2) in 69.9% and 9.0% of the cases, respectively. In the remaining 21.1% of the patients, pb-CFR was "indeterminate". In this cohort, pb-CFR correlated poorly with thermodilution-derived coronary flow reserve (k=0.03, p=0.39). The IMR was significantly different across the pb-CFR subgroups. Similarly, significant differences were observed in MVO, myocardium area at risk and 48-hour infarct size (IS). A trend towards lower six-month IS was observed in patients with high (>2) post-PPCI pb-CFR. Nevertheless, pb-CFR was inferior to IMR in predicting MVO and the extent of IS. CONCLUSIONS Pb-CFR can identify microvascular dysfunction in patients after STEMI. It provided superior diagnostic performance compared to thermodilution-derived CFR in predicting MVO. However, IMR was superior to both pb-CFR and thermodilution-derived CFR and, consequently, IMR was the most accurate in predicting all of the studied CMR endpoints of myocardial injury after PPCI.
Collapse
Affiliation(s)
- Roberto Scarsini
- Oxford Heart Centre, NIHR Biomedical Research Centre, Oxford University Hospitals, Oxford, United Kingdom,Division of Cardiology, Department of Medicine, University of Verona, Verona, Italy
| | - Giovanni Luigi De Maria
- Oxford Heart Centre, NIHR Biomedical Research Centre, Oxford University Hospitals, Oxford, United Kingdom
| | - Mayooran Shanmuganathan
- Oxford Heart Centre, NIHR Biomedical Research Centre, Oxford University Hospitals, Oxford, United Kingdom,Oxford Centre for Clinical Magnetic Resonance Research, Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom
| | - Rafail Kotronias
- Oxford Heart Centre, NIHR Biomedical Research Centre, Oxford University Hospitals, Oxford, United Kingdom,Division of Cardiovascular Medicine, BHF Centre of Research Excellence, University of Oxford, Oxford, United Kingdom
| | | | - Jeremy Langrish
- Oxford Heart Centre, NIHR Biomedical Research Centre, Oxford University Hospitals, Oxford, United Kingdom
| | - Andrew Lucking
- Oxford Heart Centre, NIHR Biomedical Research Centre, Oxford University Hospitals, Oxford, United Kingdom
| | - Flavio L. Ribichini
- Division of Cardiology, Department of Medicine, University of Verona, Verona, Italy
| | - Robin Choudhury
- Oxford Heart Centre, NIHR Biomedical Research Centre, Oxford University Hospitals, Oxford, United Kingdom,Acute Vascular Imaging Centre, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom
| | - Rajesh K. K. Kharbanda
- Oxford Heart Centre, NIHR Biomedical Research Centre, Oxford University Hospitals, Oxford, United Kingdom,Division of Cardiovascular Medicine, BHF Centre of Research Excellence, University of Oxford, Oxford, United Kingdom
| | - Vanessa Ferreira
- Oxford Heart Centre, NIHR Biomedical Research Centre, Oxford University Hospitals, Oxford, United Kingdom,Oxford Centre for Clinical Magnetic Resonance Research, Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom
| | - Keith Channon
- Oxford Heart Centre, NIHR Biomedical Research Centre, Oxford University Hospitals, Oxford, United Kingdom,Division of Cardiovascular Medicine, BHF Centre of Research Excellence, University of Oxford, Oxford, United Kingdom
| | - Adrian P. Banning
- Oxford Heart Centre, Oxford University Hospitals, Headley Way, Oxford, OX3 9DU, United Kingdom
| | | |
Collapse
|
8
|
Muroya T, Kawano H, Hata S, Shinboku H, Sonoda K, Kusumoto S, Eto R, Otsuka K, Maemura K. Relationship between resting full‐cycle ratio and fractional flow reserve in assessments of coronary stenosis severity. Catheter Cardiovasc Interv 2020; 96:E432-E438. [DOI: 10.1002/ccd.28835] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/27/2019] [Revised: 01/28/2020] [Accepted: 02/25/2020] [Indexed: 11/06/2022]
Affiliation(s)
- Takahiro Muroya
- Circulatory Division Sasebo City General Hospital Nagasaki Japan
| | - Hiroaki Kawano
- Department of Cardiovascular Medicine Nagasaki University Graduate School of Biomedical Sciences Nagasaki Japan
| | - Shiro Hata
- Circulatory Division Sasebo City General Hospital Nagasaki Japan
| | - Hiroki Shinboku
- Circulatory Division Sasebo City General Hospital Nagasaki Japan
| | - Koichiro Sonoda
- Circulatory Division Sasebo City General Hospital Nagasaki Japan
| | - Saburo Kusumoto
- Circulatory Division Sasebo City General Hospital Nagasaki Japan
| | - Ryo Eto
- Circulatory Division Sasebo City General Hospital Nagasaki Japan
| | - Kaishi Otsuka
- Circulatory Division Sasebo City General Hospital Nagasaki Japan
| | - Koji Maemura
- Department of Cardiovascular Medicine Nagasaki University Graduate School of Biomedical Sciences Nagasaki Japan
| |
Collapse
|
9
|
Wijntjens GW, van Lavieren MA, van de Hoef TP, Echavarría-Pinto M, Meuwissen M, Stegehuis VE, Murai T, Escaned J, Piek JJ. Pressure-derived estimations of coronary flow reserve are inferior to flow-derived coronary flow reserve as diagnostic and risk stratification tools. Int J Cardiol 2019; 279:6-11. [DOI: 10.1016/j.ijcard.2018.11.013] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/05/2018] [Revised: 10/25/2018] [Accepted: 11/05/2018] [Indexed: 11/29/2022]
|
10
|
Kawase Y, Matsuo H, Akasaka T, Shiono Y, Tanaka N, Amano T, Kozuma K, Nakamura M, Yokoi H, Kobayashi Y, Ikari Y. Clinical use of physiological lesion assessment using pressure guidewires: an expert consensus document of the Japanese Association of Cardiovascular Intervention and Therapeutics. Cardiovasc Interv Ther 2018; 34:85-96. [PMID: 30588572 DOI: 10.1007/s12928-018-0559-0] [Citation(s) in RCA: 30] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2018] [Accepted: 11/20/2018] [Indexed: 01/10/2023]
Abstract
In this document, the background, concept, and current evidence are briefly summarized. The focus is on the clinical application of physiological lesion assessment from a practical standpoint for facilities that do not have ample experience. Finally, the characteristics of new resting indexes are summarized.
Collapse
|
11
|
Lee JM, Rhee TM, Hwang D, Park J, Kim CH, Choi KH, Shin ES, Nam CW, Doh JH, Koo BK. Prognostic implication of thermodilution coronary flow reserve in patients with indeterminate pressure-bounded coronary flow reserve. Int J Cardiol 2018; 261:24-27. [PMID: 29657049 DOI: 10.1016/j.ijcard.2018.02.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/17/2017] [Revised: 01/29/2018] [Accepted: 02/01/2018] [Indexed: 10/17/2022]
Abstract
BACKGROUND Recently, the concept of pressure-bounded coronary flow reserve (PB-CFR) has been introduced. However, using pressure-only data, a substantial proportion of patients could not be classified into high or low PB-CFR and remained as indeterminate PB-CFR. The current study evaluated the prognostic implication of thermodilution-based CFR (thermo-CFR) in patients with indeterminate PB-CFR. METHODS Among 199 patients (211 lesions) with indeterminate PB-CFR, 170 patients (179 lesions) with deferral of revascularization were analyzed for the current study. The rates of patient-oriented composite outcomes (POCO, a composite of all-cause mortality, any myocardial infarction, and any ischemia-driven revascularization) were compared according to thermo-CFR. All patients underwent fractional flow reserve (FFR) and thermo-CFR measurements. Thermo-CFR ≤ 2.0 was classified as low thermo-CFR. The median follow-up duration was 1350.0 (Q1-Q3 1252.0-1468.0) days. RESULTS Mean angiographic percent diameter stenosis, FFR, and thermo-CFR were 42.3 ± 13.9, 0.84 ± 0.06, and 3.10 ± 1.15, respectively. Among 170 patients, 36 patients (21.2%) showed low thermo-CFR. Patients with low thermo-CFR showed significantly higher rate of POCO compared to those with high thermo-CFR (30.6% vs. 3.0%, HR 12.117, 95% CI 3.854-38.091, p < 0.001). Adding thermo-CFR to a prediction model with FFR significantly increased discrimination and reclassification index for the risk of POCO (c-index 0.545 vs. 0.766, p = 0.002, category-free net reclassification index 1.169, p < 0.001, relative integrated discrimination index 31.828, p < 0.001). CONCLUSIONS Patients with low thermo-CFR showed a significantly higher risk of POCO compared to those with high thermo-CFR among patients with indeterminate PB-CFR. Thermo-CFR showed additional prognostic implication, in addition to FFR, in patients with indeterminate PB-CFR.
Collapse
Affiliation(s)
- Joo Myung Lee
- Division of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University, School of Medicine, Seoul, Republic of Korea
| | - Tae-Min Rhee
- Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, Republic of Korea; Underwater Medical Institute, National Maritime Medical Center, Republic of Korea Navy, Changwon, Republic of Korea
| | - Doyeon Hwang
- Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, Republic of Korea
| | - Jonghanne Park
- Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, Republic of Korea; Department of Internal Medicine, Naju National Hospital, Ministry of Health and Welfare, Naju, Republic of Korea
| | - Chee Hae Kim
- Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, Republic of Korea
| | - Ki Hong Choi
- Division of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University, School of Medicine, Seoul, Republic of Korea
| | - Eun-Seok Shin
- Department of Cardiology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea; Division of Cardiology, Dietrich Bonhoeffer Hospital, Academic Teaching Hospital of University of Greifswald, Greifswald, Germany
| | - Chang-Wook Nam
- Department of Medicine, Keimyung University Dongsan Medical Center, Daegu, Republic of Korea
| | - Joon-Hyung Doh
- Department of Medicine, Inje University Ilsan Paik Hospital, Goyang, Republic of Korea
| | - Bon-Kwon Koo
- Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, Republic of Korea; Institute on Aging, Seoul National University, Seoul, Republic of Korea.
| |
Collapse
|
12
|
Cook CM, Jeremias A, Petraco R, Sen S, Nijjer S, Shun-Shin MJ, Ahmad Y, de Waard G, van de Hoef T, Echavarria-Pinto M, van Lavieren M, Al Lamee R, Kikuta Y, Shiono Y, Buch A, Meuwissen M, Danad I, Knaapen P, Maehara A, Koo BK, Mintz GS, Escaned J, Stone GW, Francis DP, Mayet J, Piek JJ, van Royen N, Davies JE. Fractional Flow Reserve/Instantaneous Wave-Free Ratio Discordance in Angiographically Intermediate Coronary Stenoses: An Analysis Using Doppler-Derived Coronary Flow Measurements. JACC Cardiovasc Interv 2017; 10:2514-2524. [PMID: 29268881 PMCID: PMC5743106 DOI: 10.1016/j.jcin.2017.09.021] [Citation(s) in RCA: 100] [Impact Index Per Article: 12.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/19/2017] [Revised: 09/15/2017] [Accepted: 09/19/2017] [Indexed: 01/10/2023]
Abstract
OBJECTIVES The study sought to determine the coronary flow characteristics of angiographically intermediate stenoses classified as discordant by fractional flow reserve (FFR) and instantaneous wave-free ratio (iFR). BACKGROUND Discordance between FFR and iFR occurs in up to 20% of cases. No comparisons have been reported between the coronary flow characteristics of FFR/iFR discordant and angiographically unobstructed vessels. METHODS Baseline and hyperemic coronary flow velocity and coronary flow reserve (CFR) were compared across 5 vessel groups: FFR+/iFR+ (108 vessels, n = 91), FFR-/iFR+ (28 vessels, n = 24), FFR+/iFR- (22 vessels, n = 22), FFR-/iFR- (208 vessels, n = 154), and an unobstructed vessel group (201 vessels, n = 153), in a post hoc analysis of the largest combined pressure and Doppler flow velocity registry (IDEAL [Iberian-Dutch-English] collaborators study). RESULTS FFR disagreed with iFR in 14% (50 of 366). Baseline flow velocity was similar across all 5 vessel groups, including the unobstructed vessel group (p = 0.34 for variance). In FFR+/iFR- discordants, hyperemic flow velocity and CFR were similar to both FFR-/iFR- and unobstructed groups; 37.6 (interquartile range [IQR]: 26.1 to 50.4) cm/s vs. 40.0 [IQR: 29.7 to 52.3] cm/s and 42.2 [IQR: 33.8 to 53.2] cm/s and CFR 2.36 [IQR: 1.93 to 2.81] vs. 2.41 [IQR: 1.84 to 2.94] and 2.50 [IQR: 2.11 to 3.17], respectively (p > 0.05 for all). In FFR-/iFR+ discordants, hyperemic flow velocity, and CFR were similar to the FFR+/iFR+ group; 28.2 (IQR: 20.5 to 39.7) cm/s versus 23.5 (IQR: 16.4 to 34.9) cm/s and CFR 1.44 (IQR: 1.29 to 1.85) versus 1.39 (IQR: 1.06 to 1.88), respectively (p > 0.05 for all). CONCLUSIONS FFR/iFR disagreement was explained by differences in hyperemic coronary flow velocity. Furthermore, coronary stenoses classified as FFR+/iFR- demonstrated similar coronary flow characteristics to angiographically unobstructed vessels.
Collapse
Affiliation(s)
| | - Allen Jeremias
- St. Francis Hospital, Roslyn, New York; Cardiovascular Research Foundation, New York, New York
| | | | - Sayan Sen
- Imperial College London, London, United Kingdom
| | | | | | | | - Guus de Waard
- VU University Medical Centre, Amsterdam, the Netherlands
| | | | | | | | | | | | | | - Ashesh Buch
- East Carolina Heart Institute at East Carolina University, Greenville, North Carolina
| | | | - Ibrahim Danad
- VU University Medical Centre, Amsterdam, the Netherlands
| | - Paul Knaapen
- VU University Medical Centre, Amsterdam, the Netherlands
| | - Akiko Maehara
- Cardiovascular Research Foundation, New York, New York; Department of Medicine, Columbia University Medical Center, New York, New York
| | - Bon-Kwon Koo
- Seoul National University Hospital, Seoul, Republic of Korea
| | - Gary S Mintz
- Cardiovascular Research Foundation, New York, New York; Department of Medicine, Columbia University Medical Center, New York, New York
| | - Javier Escaned
- Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain
| | - Gregg W Stone
- Cardiovascular Research Foundation, New York, New York; Department of Medicine, Columbia University Medical Center, New York, New York
| | | | - Jamil Mayet
- Imperial College London, London, United Kingdom
| | - Jan J Piek
- Academic Medical Centre, Amsterdam, the Netherlands
| | | | | |
Collapse
|
13
|
Ahn JM, Zimmermann FM, Johnson NP, Shin ES, Koo BK, Lee PH, Park DW, Kang SJ, Lee SW, Kim YH, Lee CW, Park SW, Pijls NH, Park SJ. Fractional flow reserve and pressure-bounded coronary flow reserve to predict outcomes in coronary artery disease. Eur Heart J 2017; 38:1980-1989. [DOI: 10.1093/eurheartj/ehx139] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/03/2016] [Accepted: 04/12/2017] [Indexed: 11/14/2022] Open
|
14
|
Zimmermann FM, Pijls NHJ, De Bruyne B, Bech GJW, van Schaardenburgh P, Kirkeeide RL, Gould KL, Johnson NP. What can intracoronary pressure measurements tell us about flow reserve? Pressure-Bounded coronary flow reserve and example application to the randomized DEFER trial. Catheter Cardiovasc Interv 2017; 90:917-925. [DOI: 10.1002/ccd.26972] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/23/2016] [Accepted: 01/16/2017] [Indexed: 11/10/2022]
Affiliation(s)
| | - Nico H. J. Pijls
- Department of Cardiology; Catharina Hospital; Eindhoven The Netherlands
- Department of Biomedical Engineering; Eindhoven University of Technology; Eindhoven The Netherlands
| | | | | | | | - Richard L. Kirkeeide
- Weatherhead PET Center; Division of Cardiology, Department of Medicine, McGovern Medical School at UTHealth and Memorial Hermann Hospital; Houston Texas
| | - K. Lance Gould
- Weatherhead PET Center; Division of Cardiology, Department of Medicine, McGovern Medical School at UTHealth and Memorial Hermann Hospital; Houston Texas
| | - Nils P. Johnson
- Department of Cardiology; Catharina Hospital; Eindhoven The Netherlands
- Weatherhead PET Center; Division of Cardiology, Department of Medicine, McGovern Medical School at UTHealth and Memorial Hermann Hospital; Houston Texas
| |
Collapse
|
15
|
Correlation between microvascular dysfunction and B-type natriuretic peptide levels in non-ischemic heart failure patients with cardiac fibrosis. Int J Cardiol 2017; 228:881-885. [DOI: 10.1016/j.ijcard.2016.11.054] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/01/2016] [Accepted: 11/05/2016] [Indexed: 01/09/2023]
|
16
|
One-Dimensional Modelling of the Coronary Circulation. Application to Noninvasive Quantification of Fractional Flow Reserve (FFR). ACTA ACUST UNITED AC 2015. [DOI: 10.1007/978-3-319-15799-3_11] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register]
|
17
|
Petraco R, van de Hoef TP, Nijjer S, Sen S, van Lavieren MA, Foale RA, Meuwissen M, Broyd C, Echavarria-Pinto M, Foin N, Malik IS, Mikhail GW, Hughes AD, Francis DP, Mayet J, Di Mario C, Escaned J, Piek JJ, Davies JE. Baseline instantaneous wave-free ratio as a pressure-only estimation of underlying coronary flow reserve: results of the JUSTIFY-CFR Study (Joined Coronary Pressure and Flow Analysis to Determine Diagnostic Characteristics of Basal and Hyperemic Indices of Functional Lesion Severity-Coronary Flow Reserve). Circ Cardiovasc Interv 2014; 7:492-502. [PMID: 24987048 DOI: 10.1161/circinterventions.113.000926] [Citation(s) in RCA: 137] [Impact Index Per Article: 12.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
BACKGROUND Coronary flow reserve has extensive validation as a prognostic marker in coronary disease. Although pressure-only fractional flow reserve (FFR) improves outcomes compared with angiography when guiding percutaneous coronary intervention, it disagrees with coronary flow reserve classification 30% of the time. We evaluated whether baseline instantaneous wave-free ratio (iFR) could provide an improved pressure-only estimation of underlying coronary flow reserve. METHODS AND RESULTS Invasive pressure and flow velocity were measured in 216 stenoses from 186 patients with coronary disease. The diagnostic relationship between pressure-only indices (iFR and FFR) and coronary flow velocity reserve (CFVR) was compared using correlation coefficient and the area under the receiver operating characteristic curve. iFR showed a stronger correlation with underlying CFVR (iFR-CFVR, ρ=0.68 versus FFR-CFVR, ρ=0.50; P<0.001). iFR also agreed more closely with CFVR in stenosis classification (iFR area under the receiver operating characteristic curve, 0.82 versus FFR area under the receiver operating characteristic curve, 0.72; P<0.001, for a CFVR of 2). The closer relationship between iFR and CFVR was found for different CFVR cutoffs and was particularly marked in the 0.6 to 0.9 FFR range. Hyperemic FFR flow was similar to baseline iFR flow in functionally significant lesions (FFR ≤0.75; mean FFR flow, 25.8±13.7 cm/s versus mean iFR flow, 21.5±11.7 cm/s; P=0.13). FFR flow was higher than iFR flow in nonsignificant stenoses (FFR >0.75; mean FFR flow, 42.3±22.8 cm/s versus mean iFR flow, 26.1±15.5 cm/s; P<0.001). CONCLUSIONS When compared with FFR, iFR shows stronger correlation and better agreement with CFVR. These results provide physiological evidence that iFR could potentially be used as a functional index of disease severity, independently from its agreement with FFR.
Collapse
Affiliation(s)
- Ricardo Petraco
- From the International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London and Imperial College Healthcare NHS Trust, London, United Kingdom (R.P., S.N., S.S., R.A.F., C.B., N.F., I.S.M., G.W.M., A.D.H., D.P.F., J.M., C.D.M., J.E.D.); Department of Cardiology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands (T.P.v.d.H., M.A.v.L., J.J.P.); Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain (M.E.-P., J.E.); Amphia Hospital, Breda, The Netherlands (M.M.); and Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (C.D.M.)
| | - Tim P van de Hoef
- From the International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London and Imperial College Healthcare NHS Trust, London, United Kingdom (R.P., S.N., S.S., R.A.F., C.B., N.F., I.S.M., G.W.M., A.D.H., D.P.F., J.M., C.D.M., J.E.D.); Department of Cardiology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands (T.P.v.d.H., M.A.v.L., J.J.P.); Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain (M.E.-P., J.E.); Amphia Hospital, Breda, The Netherlands (M.M.); and Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (C.D.M.)
| | - Sukhjinder Nijjer
- From the International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London and Imperial College Healthcare NHS Trust, London, United Kingdom (R.P., S.N., S.S., R.A.F., C.B., N.F., I.S.M., G.W.M., A.D.H., D.P.F., J.M., C.D.M., J.E.D.); Department of Cardiology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands (T.P.v.d.H., M.A.v.L., J.J.P.); Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain (M.E.-P., J.E.); Amphia Hospital, Breda, The Netherlands (M.M.); and Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (C.D.M.)
| | - Sayan Sen
- From the International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London and Imperial College Healthcare NHS Trust, London, United Kingdom (R.P., S.N., S.S., R.A.F., C.B., N.F., I.S.M., G.W.M., A.D.H., D.P.F., J.M., C.D.M., J.E.D.); Department of Cardiology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands (T.P.v.d.H., M.A.v.L., J.J.P.); Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain (M.E.-P., J.E.); Amphia Hospital, Breda, The Netherlands (M.M.); and Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (C.D.M.)
| | - Martijn A van Lavieren
- From the International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London and Imperial College Healthcare NHS Trust, London, United Kingdom (R.P., S.N., S.S., R.A.F., C.B., N.F., I.S.M., G.W.M., A.D.H., D.P.F., J.M., C.D.M., J.E.D.); Department of Cardiology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands (T.P.v.d.H., M.A.v.L., J.J.P.); Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain (M.E.-P., J.E.); Amphia Hospital, Breda, The Netherlands (M.M.); and Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (C.D.M.)
| | - Rodney A Foale
- From the International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London and Imperial College Healthcare NHS Trust, London, United Kingdom (R.P., S.N., S.S., R.A.F., C.B., N.F., I.S.M., G.W.M., A.D.H., D.P.F., J.M., C.D.M., J.E.D.); Department of Cardiology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands (T.P.v.d.H., M.A.v.L., J.J.P.); Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain (M.E.-P., J.E.); Amphia Hospital, Breda, The Netherlands (M.M.); and Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (C.D.M.)
| | - Martijn Meuwissen
- From the International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London and Imperial College Healthcare NHS Trust, London, United Kingdom (R.P., S.N., S.S., R.A.F., C.B., N.F., I.S.M., G.W.M., A.D.H., D.P.F., J.M., C.D.M., J.E.D.); Department of Cardiology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands (T.P.v.d.H., M.A.v.L., J.J.P.); Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain (M.E.-P., J.E.); Amphia Hospital, Breda, The Netherlands (M.M.); and Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (C.D.M.)
| | - Christopher Broyd
- From the International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London and Imperial College Healthcare NHS Trust, London, United Kingdom (R.P., S.N., S.S., R.A.F., C.B., N.F., I.S.M., G.W.M., A.D.H., D.P.F., J.M., C.D.M., J.E.D.); Department of Cardiology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands (T.P.v.d.H., M.A.v.L., J.J.P.); Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain (M.E.-P., J.E.); Amphia Hospital, Breda, The Netherlands (M.M.); and Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (C.D.M.)
| | - Mauro Echavarria-Pinto
- From the International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London and Imperial College Healthcare NHS Trust, London, United Kingdom (R.P., S.N., S.S., R.A.F., C.B., N.F., I.S.M., G.W.M., A.D.H., D.P.F., J.M., C.D.M., J.E.D.); Department of Cardiology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands (T.P.v.d.H., M.A.v.L., J.J.P.); Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain (M.E.-P., J.E.); Amphia Hospital, Breda, The Netherlands (M.M.); and Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (C.D.M.)
| | - Nicolas Foin
- From the International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London and Imperial College Healthcare NHS Trust, London, United Kingdom (R.P., S.N., S.S., R.A.F., C.B., N.F., I.S.M., G.W.M., A.D.H., D.P.F., J.M., C.D.M., J.E.D.); Department of Cardiology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands (T.P.v.d.H., M.A.v.L., J.J.P.); Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain (M.E.-P., J.E.); Amphia Hospital, Breda, The Netherlands (M.M.); and Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (C.D.M.)
| | - Iqbal S Malik
- From the International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London and Imperial College Healthcare NHS Trust, London, United Kingdom (R.P., S.N., S.S., R.A.F., C.B., N.F., I.S.M., G.W.M., A.D.H., D.P.F., J.M., C.D.M., J.E.D.); Department of Cardiology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands (T.P.v.d.H., M.A.v.L., J.J.P.); Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain (M.E.-P., J.E.); Amphia Hospital, Breda, The Netherlands (M.M.); and Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (C.D.M.)
| | - Ghada W Mikhail
- From the International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London and Imperial College Healthcare NHS Trust, London, United Kingdom (R.P., S.N., S.S., R.A.F., C.B., N.F., I.S.M., G.W.M., A.D.H., D.P.F., J.M., C.D.M., J.E.D.); Department of Cardiology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands (T.P.v.d.H., M.A.v.L., J.J.P.); Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain (M.E.-P., J.E.); Amphia Hospital, Breda, The Netherlands (M.M.); and Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (C.D.M.)
| | - Alun D Hughes
- From the International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London and Imperial College Healthcare NHS Trust, London, United Kingdom (R.P., S.N., S.S., R.A.F., C.B., N.F., I.S.M., G.W.M., A.D.H., D.P.F., J.M., C.D.M., J.E.D.); Department of Cardiology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands (T.P.v.d.H., M.A.v.L., J.J.P.); Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain (M.E.-P., J.E.); Amphia Hospital, Breda, The Netherlands (M.M.); and Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (C.D.M.)
| | - Darrel P Francis
- From the International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London and Imperial College Healthcare NHS Trust, London, United Kingdom (R.P., S.N., S.S., R.A.F., C.B., N.F., I.S.M., G.W.M., A.D.H., D.P.F., J.M., C.D.M., J.E.D.); Department of Cardiology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands (T.P.v.d.H., M.A.v.L., J.J.P.); Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain (M.E.-P., J.E.); Amphia Hospital, Breda, The Netherlands (M.M.); and Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (C.D.M.)
| | - Jamil Mayet
- From the International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London and Imperial College Healthcare NHS Trust, London, United Kingdom (R.P., S.N., S.S., R.A.F., C.B., N.F., I.S.M., G.W.M., A.D.H., D.P.F., J.M., C.D.M., J.E.D.); Department of Cardiology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands (T.P.v.d.H., M.A.v.L., J.J.P.); Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain (M.E.-P., J.E.); Amphia Hospital, Breda, The Netherlands (M.M.); and Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (C.D.M.)
| | - Carlo Di Mario
- From the International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London and Imperial College Healthcare NHS Trust, London, United Kingdom (R.P., S.N., S.S., R.A.F., C.B., N.F., I.S.M., G.W.M., A.D.H., D.P.F., J.M., C.D.M., J.E.D.); Department of Cardiology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands (T.P.v.d.H., M.A.v.L., J.J.P.); Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain (M.E.-P., J.E.); Amphia Hospital, Breda, The Netherlands (M.M.); and Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (C.D.M.)
| | - Javier Escaned
- From the International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London and Imperial College Healthcare NHS Trust, London, United Kingdom (R.P., S.N., S.S., R.A.F., C.B., N.F., I.S.M., G.W.M., A.D.H., D.P.F., J.M., C.D.M., J.E.D.); Department of Cardiology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands (T.P.v.d.H., M.A.v.L., J.J.P.); Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain (M.E.-P., J.E.); Amphia Hospital, Breda, The Netherlands (M.M.); and Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (C.D.M.)
| | - Jan J Piek
- From the International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London and Imperial College Healthcare NHS Trust, London, United Kingdom (R.P., S.N., S.S., R.A.F., C.B., N.F., I.S.M., G.W.M., A.D.H., D.P.F., J.M., C.D.M., J.E.D.); Department of Cardiology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands (T.P.v.d.H., M.A.v.L., J.J.P.); Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain (M.E.-P., J.E.); Amphia Hospital, Breda, The Netherlands (M.M.); and Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (C.D.M.)
| | - Justin E Davies
- From the International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London and Imperial College Healthcare NHS Trust, London, United Kingdom (R.P., S.N., S.S., R.A.F., C.B., N.F., I.S.M., G.W.M., A.D.H., D.P.F., J.M., C.D.M., J.E.D.); Department of Cardiology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands (T.P.v.d.H., M.A.v.L., J.J.P.); Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain (M.E.-P., J.E.); Amphia Hospital, Breda, The Netherlands (M.M.); and Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (C.D.M.).
| |
Collapse
|
18
|
Niccoli G, Falcioni E, Cosentino N, Fracassi F, Roberto M, Fabretti A, Panebianco M, Scalone G, Burzotta F, Trani C, Leone AM, Davies J, Crea F. Impact of accuracy of fractional flow reserve to reduction of microvascular resistance after intracoronary adenosine in patients with angina pectoris or non-ST-segment elevation myocardial infarction. Am J Cardiol 2014; 113:1461-7. [PMID: 24731651 DOI: 10.1016/j.amjcard.2014.01.422] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/11/2013] [Revised: 01/14/2014] [Accepted: 01/14/2014] [Indexed: 01/07/2023]
Abstract
Our study aimed to elucidate mechanisms underlying discordance between fractional flow reserve (FFR) and hyperemic stenosis resistance (hSR) in some patient subsets. To do this, we enrolled 30 consecutive patients with stable angina or non-ST elevation myocardial infarction (non-STEMI) and with a nonculprit intermediate coronary lesion (40% to 70%) by coronary angiography. We measured aortic pressure, flow velocity, and pressure distal to lesion simultaneously at basal level and during adenosine-induced (fixed intracoronary dose of 120 μg) hyperemia using a dual-sensor-equipped guidewire. Microvascular resistance (MR; pressure distal to lesion/flow velocity, mm Hg/cm/s) and variation (Δ) in MR levels were calculated both at baseline and after hyperemia, whereas FFR (cutoff <0.80) and hSR [(aortic pressure - pressure distal to lesion)/flow velocity, cutoff >0.80 mm Hg/cm/s] were assessed after intracoronary adenosine. Twenty-three patients (76.7%) showed concordance and 7 patients (23.3%) showed discordance between FFR and hSR (all cases with FFR >0.80 and hSR >0.80). Discordant patients presented more frequently with non-STEMI (85.7% vs 39.1%, p = 0.04), significantly higher C-reactive protein serum levels (median [interquartile range] 5.9 [5.1 to 6.8] vs 4.9 [3.7 to 6.2] mg/L, p = 0.007), and lower ΔMR (p = 0.03) values compared with concordant patients. In conclusion, patients with non-STEMI and those with increased C-reactive protein levels show a lower reduction in MR after intracoronary adenosine-induced hyperemia, leading to FFR underestimation.
Collapse
Affiliation(s)
- Giampaolo Niccoli
- Department of Cardiovascular Medicine, Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy.
| | - Elena Falcioni
- Department of Cardiovascular Medicine, Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy
| | - Nicola Cosentino
- Department of Cardiovascular Medicine, Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy
| | - Francesco Fracassi
- Department of Cardiovascular Medicine, Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy
| | - Marco Roberto
- Department of Cardiovascular Medicine, Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy
| | - Alessandro Fabretti
- Department of Cardiovascular Medicine, Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy
| | - Mario Panebianco
- Department of Cardiovascular Medicine, Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy
| | - Giancarla Scalone
- Department of Cardiovascular Medicine, Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy
| | - Francesco Burzotta
- Department of Cardiovascular Medicine, Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy
| | - Carlo Trani
- Department of Cardiovascular Medicine, Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy
| | - Antonio Maria Leone
- Department of Cardiovascular Medicine, Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy
| | - Justin Davies
- International Centre for Circulatory Health, NHLI, Imperial College London, London, United Kingdom
| | - Filippo Crea
- Department of Cardiovascular Medicine, Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy
| |
Collapse
|
19
|
Kim JH, Park JH, Choo K, Song SK, Kim JS, Park YH, Kim J, Chun KJ, Han D, Faranesh AZ, Lederman RJ. Pressure-wire based assessment of microvascular resistance using calibrated upstream balloon obstruction: a predictor of myocardial viability. Catheter Cardiovasc Interv 2011; 80:581-9. [PMID: 21805603 DOI: 10.1002/ccd.23277] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/18/2011] [Accepted: 06/08/2011] [Indexed: 12/20/2022]
Abstract
OBJECTIVES We assess microvascular integrity as a marker of myocardial viability after coronary stenting, using only a pressure guidewire. BACKGROUND Microvascular integrity generally is not assessed using pressure-only guidewires because the transducer lies upstream of microvasculature. We partially inflate a balloon inside a coronary stent to achieve a specific normalized pressure drop at rest (distal coronary/aortic pressure = 0.8) and then infuse a vasodilator, to render the wire sensitive to microvascular function. We hypothesize that the further decline in pressure (ΔFFR(0.8) ) predicts MRI myocardial viability. METHODS We studied 29 subjects with acute coronary syndrome including myocardial infarction. After successful culprit stenting, the resting coronary/aortic pressure was set to 0.8 using temporary balloon obstruction. ΔFFR(0.8) was defined as 0.8-(distal coronary/aortic pressures) during adenosine-induced hyperemia. The average transmural extent of infarction was defined as the average area of MRI late gadolinium enhancement (after 2.8 ± 1.5 days) divided by the corresponding full thickness of the gadolinium enhanced sector in short axis slices, and was compared with ΔFFR(0.8) . RESULTS ΔFFR(0.8) corresponded inversely and linearly with the average transmural extent of infarction (r(2) = 0.65, P < 0.001). We found that a transmural extent of infarction of 0.50 corresponded to a ΔFFR(0.8) threshold of 0.1, and had high sensitivity and specificity (100% and 94.4%, respectively). CONCLUSIONS Using only an upstream pressure-sensitive guidewire and a partially obstructing balloon during pharmacologic hyperemia, we were able to predict MRI myocardial viability with high accuracy after relief of epicardial stenosis. With further validation, this may prove a useful clinical prognostic tool after percutaneous intervention.
Collapse
Affiliation(s)
- June-Hong Kim
- Division of Cardiology, Department of Internal Medicine and Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
20
|
Yamada R, Okura H, Kume T, Neishi Y, Kawamoto T, Miyamoto Y, Imai K, Saito K, Tsuchiya T, Hayashida A, Yoshida K. Target Lesion Thin-Cap Fibroatheroma Defined by Virtual Histology Intravascular Ultrasound Affects Microvascular Injury During Percutaneous Coronary Intervention in Patients With Angina Pectoris. Circ J 2010; 74:1658-62. [DOI: 10.1253/circj.cj-09-0992] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
| | | | - Teruyoshi Kume
- Division of Cardiovascular Medicine, Stanford University
| | - Yoji Neishi
- Division of Cardiology, Kawasaki Medical School
| | | | | | | | - Ken Saito
- Division of Cardiology, Kawasaki Medical School
| | | | | | | |
Collapse
|
21
|
Sinha Roy A, Back MR, Khoury SF, Schneeberger EW, Back LH, Velury VV, Millard RW, Banerjee RK. Functional and anatomical diagnosis of coronary artery stenoses. J Surg Res 2007; 150:24-33. [PMID: 18262546 DOI: 10.1016/j.jss.2007.10.018] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2007] [Revised: 10/16/2007] [Accepted: 10/21/2007] [Indexed: 02/07/2023]
Abstract
BACKGROUND Functional/physiological evaluation of coronary artery stenoses may be more important than anatomical measurements of severity. Optimization of thresholds for stenosis intervention and treatment endpoints depend on coupling functional hemodynamic and anatomical data. We sought to develop a single prognostic parameter correlating stenosis-specific anatomy, pressure gradient, and velocities that could be measured during catheterization. MATERIALS AND METHODS In vivo Experiments were performed in six swine (41 +/- 3 kg). The lumen area of the left anterior descending coronary artery was measured with intravascular ultrasound. An angioplasty balloon was inflated to create the desired intraluminal area obstructions. Fractional flow reserve (FFR), coronary flow reserve (CFR), and hyperemic-stenosis-resistance index were measured distal to the balloon at peak hyperemia with 10 mg intracoronary papaverine. A functional index:pressure drop coefficient (CDP) and a combined functional and anatomical index:lesion flow coefficient (LFC) were calculated from measured hyperemic pressure gradient, velocity, and percentage area stenosis. P < 0.05 was considered statistically significant. RESULTS The CDP and LFC correlated linearly and significantly with FFR and CFR. The CDP (R(2) = 0.72, P < 0.0001) correlated better than LFC (R(2) = 0.19, P < 0.003) with hyperemic-stenosis-resistance index. When LFC was correlated simultaneously with FFR and CFR, R(2) improved to 0.82 (P < 0.0001). Inclusion of percentage area stenoses concurrently with FFR and CFR marginally improved the correlation with LFC. CONCLUSIONS A dimensionless parameter combining measured pressure gradient, velocity, and area reduction data can optimally define the severity of coronary stenoses based on our preliminary results and could prove useful clinically.
Collapse
Affiliation(s)
- Abhijit Sinha Roy
- Department of Mechanical Engineering, University of Cincinnati, Cincinnati, Ohio 45221-0072, USA
| | | | | | | | | | | | | | | |
Collapse
|
22
|
Takagi T, Takagi A, Hozumi T, Yoshikawa J. Detection of significant stenotic lesions in the left anterior descending coronary artery using adenosine triphosphate stress strain imaging: comparison with coronary flow velocity reserve measurement using transthoracic Doppler echocardiography. J Am Soc Echocardiogr 2006; 19:1001-11. [PMID: 16880095 DOI: 10.1016/j.echo.2006.02.009] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/30/2005] [Indexed: 11/25/2022]
Abstract
To evaluate the usefulness of adenosine triphosphate stress strain imaging for detecting significant coronary artery disease in the left anterior descending coronary artery (LAD), 34 patients underwent coronary flow velocity reserve measurement in the distal LAD and adenosine triphosphate stress strain imaging simultaneously. Time to peak strain (TPS) was measured in the apical septal segment. TPS ratio was obtained as the ratio between TPS at adenosine triphosphate stress and at baseline. TPS ratio in 11 patients with LAD lesions was significantly greater than that in 23 patients without LAD lesions (1.24 +/- 0.17 vs 0.92 +/- 0.12, respectively, P < .0001). With a cut-off value greater than or equal to 1.1 for the TPS ratio and less than 2.0 for the coronary flow velocity reserve, diagnostic accuracy for the presence of significant LAD lesions were 88% and 82%, respectively. In conclusion, strain imaging can differentiate ischemic and nonischemic myocardium accurately comparable with coronary flow velocity reserve measurement.
Collapse
|
23
|
Sorop O, Bakker ENTP, Pistea A, Spaan JAE, VanBavel E. Calcium channel blockade prevents pressure-dependent inward remodeling in isolated subendocardial resistance vessels. Am J Physiol Heart Circ Physiol 2006; 291:H1236-45. [PMID: 16565310 DOI: 10.1152/ajpheart.00838.2005] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
The capacity for myocardial perfusion depends on the structure of the coronary microvascular bed. Coronary microvessels may adapt their structure to various stimuli. We tested whether the local pressure profile affects tone and remodeling of porcine coronary microvessels. Subendocardial vessels (approximately 160 microm, n=53) were cannulated and kept in organoid culture for 3 days under different transvascular pressure profiles: Osc 80: mean 80 mmHg, 60 mmHg peak-peak sine wave pulsation amplitude at 1.5 Hz; St 80: steady 80 mmHg; Osc 40: mean 40 mmHg, 30 mmHg amplitude; St 40: steady 40 mmHg. Under the Osc 80 profile, modest tone developed, reducing the diameter to 81+/-14% (mean+/-SE, n=6) of the maximal, passive diameter. No inward remodeling was found here, as determined from the passive pressure-diameter relation after 3 days of culture. Under all other profiles, much more tone developed (e.g., Osc 40: to 26+/-3%, n=7). In addition, these vessels showed eutrophic (i.e., without a change in wall cross-sectional area) inward remodeling (e.g., Osc 40: passive diameter reduction by 24+/-3%). The calcium blocker amlodipine induced maintained dilation in St 40 vessels and reversed the 22+/-3% (n=6) inward remodeling to 15+/-3% (n=8) outward remodeling toward day 3. Vessels required a functional endothelium to maintain structural integrity in culture. Our data indicate that reduction of either mean pressure or pulse pressure leads to microvascular constriction followed by inward remodeling. These effects could be reversed by amlodipine. Although microvascular pressure profiles distal to stenoses are poorly defined, these data suggest that vasodilator therapy could improve subendocardial microvascular function and structure in coronary artery disease.
Collapse
Affiliation(s)
- Oana Sorop
- Department of Medical Physics, Academic Medical Center, University of Amsterdam, PO Box 22700, 1100 DE Amsterdam, The Netherlands
| | | | | | | | | |
Collapse
|
24
|
Son HS, Sun K, Fang YH, Park SY, Hwang CM, Park SM, Lee SH, Kim KT, Lee IS. The effects of pulsatile versus non-pulsatile extracorporeal circulation on the pattern of coronary artery blood flow during cardiac arrest. Int J Artif Organs 2005; 28:609-16. [PMID: 16015571 DOI: 10.1177/039139880502800610] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
BACKGROUND In sudden cardiac arrest, the effective maintenance of coronary artery blood flow is of paramount importance for myocardial preservation as well as cardiac recovery and patient survival. The purpose of this study was to directly compare the effects of pulsatile versus non-pulsatile circulation to coronary artery flow and myocardial preservation in a cardiac arrest condition. METHODS A cardiopulmonary bypass circuit was constructed in a ventricular fibrillation model using fourteen Yorkshire swine weighing 25-35 kg each. The animals were randomly assigned to group I (n=7, non-pulsatile centrifugal pump) or group II (n=7, pulsatile T-PLS pump). Extracorporeal circulation was maintained for two hours at a pump flow of 2 L/min. The left anterior descending coronary artery flow was measured with an ultrasonic coronary artery flow measurement system at baseline (before bypass) and at every 20 minutes after bypass. Serologic parameters were collected simultaneously at baseline, 1 hour, and 2 hours after bypass in the systemic arterial and coronary sinus venous blood. The Mann-Whitney U test of STATISTICA 6.0 was used to determine intergroup significances using a p value of <0.05. RESULTS The resistance index of the coronary artery was lower in group II and the difference was significant at 40 min, 80 min, 100 min and 120 min (p<0.05). The mean velocity of the coronary artery was higher in group II throughout the study, and the difference was significant from 20 min after starting the pump (p<0.05). The coronary artery blood flow was higher in group II throughout the study, and the difference was significant from 40 min to 120 min (p<0.05) except at 80 min. Serologic parameters showed no differences between the groups at 1 hour and 2 hours after bypass in the systemic and coronary sinus blood (p=NS). CONCLUSION In the cardiac arrest condition, pulsatile extracorporeal circulation provides more blood flow, higher flow velocity and less resistance to coronary artery than non-pulsatile circulation.
Collapse
Affiliation(s)
- H S Son
- Department of Thoracic and Cardiovascular Surgery, Korea University, Seoul, Korea
| | | | | | | | | | | | | | | | | |
Collapse
|
25
|
MacCarthy P, Berger A, Manoharan G, Bartunek J, Barbato E, Wijns W, Heyndrickx GR, Pijls NHJ, De Bruyne B. Pressure-derived measurement of coronary flow reserve. J Am Coll Cardiol 2005; 45:216-20. [PMID: 15653018 DOI: 10.1016/j.jacc.2004.09.063] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/20/2004] [Revised: 09/06/2004] [Accepted: 09/17/2004] [Indexed: 11/25/2022]
Abstract
OBJECTIVES We aimed to validate the technique of measuring the coronary flow reserve (CFR) with coronary pressure measurements against an established thermodilution technique. BACKGROUND The CFR has traditionally required measurement of coronary blood flow velocity with the Doppler wire and, more recently, using a thermodilution technique with the coronary pressure wire. However, recent work has suggested that the CFR may be derived from pressure measurements alone (the ratio of the square root of the pressure drop across an epicardial stenosis during hyperemia to that value at rest). This depends on the assumption that friction losses across a coronary stenosis are negligible. METHODS We compared pressure-derived CFR values with those obtained by the thermodilution technique using the intracoronary pressure wire in 38 stenoses in 34 patients with significant coronary stenoses undergoing percutaneous intervention. We also compared these two techniques of measuring CFR in 25 stenoses (6 vessels) artificially created by inflating small balloons within a stented coronary artery after percutaneous intervention. RESULTS There is a close linear relationship between pressure-derived and thermodilution CFR in native (r(2) = 0.52; p < 0.001) and artificial stenoses (r(2) = 0.54; p < 0.05), although the pressure-derived technique appears to systematically underestimate CFR values in both situations. This applies to native and artificial stenoses. CONCLUSIONS Coronary flow reserve cannot be measured merely with pressure alone, and it cannot be safely assumed that friction losses are negligible across a native coronary stenosis. These data suggest that friction loss is an important determinant of the pressure gradient along an atherosclerotic coronary artery.
Collapse
|
26
|
Hirata K, Amudha K, Elina R, Hozumi T, Yoshikawa J, Homma S, Lang CC. Measurement of coronary vasomotor function: getting to the heart of the matter in cardiovascular research. Clin Sci (Lond) 2004; 107:449-60. [PMID: 15362973 DOI: 10.1042/cs20040226] [Citation(s) in RCA: 37] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Measurement of endothelial function in patients has emerged as a useful tool for cardiovascular research. Although no gold standard for the measurement of endothelial function exists, the measurement of flow-mediated dilation in the brachial artery, assessed with Doppler ultrasonography, is the most studied method. However, the assumption that endothelial dysfunction detected in brachial arteries is a manifestation of systemic endothelial dysfunction including the coronary circulation may not be entirely valid. Brachial and myocardial circulations differ in terms of the microvascular architecture, the pattern of blood flow and vascular resistance (e.g. shunt vessels occur in the hand but not in the myocardium), their metabolic regulation, type of receptors that contribute to humoral regulation and the pathways that are activated to induce hyperaemia. In this context, measuring coronary vasomotor function may be more useful than brachial artery measures to predict and assess potential myocardial damage related to limited vascular responsiveness. This review aims to provide an overview of the basic concept of coronary flow reserve and its different modalities of measurement, as well as its utility in cardiovascular research.
Collapse
Affiliation(s)
- Kumiko Hirata
- Division of Cardiology, Columbia University, New York, USA
| | | | | | | | | | | | | |
Collapse
|
27
|
Abstract
With growing numbers of patients with acute coronary syndromes undergoing catheterization without prior non-invasive imaging and the increasing numbers of patients with angiographic multivessel coronary artery disease, complementary physiologic lesion assessment for directing revascularization is of increasing value. Fractional flow reserve (FFR) has emerged as a simple, reliable, and reproducible physiologic index of lesion severity. In concert with coronary flow reserve, FFR yields significant information about the epicardial artery and the microvascular bed it subtends. This review will critically consider the theory of FFR measurements in the context of recent insights into coronary hemodynamics and how FFR measurements are significantly affected by microvascular disease states such as myocardial infarction, left ventricular hypertrophy, or diabetes mellitus. Clinical studies have demonstrated the usefulness of FFR for the assessment of intermediate lesions in single-vessel, multivessel, and possibly left main disease. In addition, measurement of fractional collateral flow reserve during angioplasty and FFR after stent deployment have prognostic value for major adverse cardiac events after percutaneous intervention. Furthermore, with economic concerns about the appropriate use of drug-eluting stents, FFR assessment can be used to direct percutaneous coronary intervention only to flow-limiting lesions and to achieve optimal stent deployment. Therefore, FFR represents a powerful new tool in the cardiologists' arsenal in the cardiac catheterization laboratory.
Collapse
Affiliation(s)
- Andrew H Bishop
- Cardiovascular Division, Department of Medicine, University of Virginia Health System, Charlottesville, Va 23502, USA
| | | |
Collapse
|